Risk Factors for Mucosal Involvement in Bullous Pemphigoid and the Possible Mechanism: A Review.

Frontiers in Medicine
Xinyi ChenLi Li

Abstract

Bullous pemphigoid (BP) is the most common type of autoimmune bullous disease and is characterized by the presence of circulating anti-BP180 and/or anti-BP230 autoantibodies. Patients with BP often present with tense blisters and erythema, mainly on the trunk and limbs, but a few patients also have mucosal involvement. In this article, we discuss the fact that BP patients with mucosal involvement tend to have more serious conditions and their disease is more difficult to control. Potential risk factors for mucous involvement include earlier age at onset, drugs such as dipeptidyl peptidase-4 inhibitors, cancer, and blood/serum biomarkers, including lower eosinophil count, higher erythrocyte sedimentation rate, IgG autoantibodies against both the NH2- and COOH-termini of BP180, and the absence of anti-BP230 antibodies. IgA and C3 deposition at the dermo-epidermal junction may also be present. Understanding these risk factors may benefit earlier diagnosis of these patients and promote the development of novel treatments. What's more, it's helpful in deeper understanding of BP development and the relationship between BP and mucous membrane pemphigoid (MMP).

References

Jul 1, 1986·Clinical and Experimental Dermatology·P D MauriceW G Reeves
Jan 1, 1997·Clinical and Experimental Dermatology·C C BanfieldF T Wojnarowska
Apr 21, 2004·Seminars in Cutaneous Medicine and Surgery·Ewa KolankoL Frank Glass
Jan 21, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sybille Thoma-UszynskiMichael Hertl
Jan 23, 2008·Archives of Dermatology·Yohei IwataShinichi Sato
Jun 24, 2008·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Giovanni Di ZenzoMichael Hertl
Jan 23, 2009·The Journal of Investigative Dermatology·Silke C HofmannClaus-Werner Franzke
Sep 18, 2009·Annals of the New York Academy of Sciences·Marilina TampoiaFrancesca Di Serio
Mar 16, 2012·The Journal of Investigative Dermatology·Pascal JolyJacques Bénichou
Jun 20, 2012·The British Journal of Dermatology·R della TorreL Borradori
Nov 6, 2012·The British Journal of Dermatology·V A VenningG Kirtschig
Jan 11, 2014·Journal of the European Academy of Dermatology and Venereology : JEADV·P G StavropoulosC Antoniou
Apr 12, 2014·The Australasian Journal of Dermatology·Sai Yee ChuahAudrey W H Tan
Jan 30, 2015·Case Reports in Otolaryngology·C M LeeJ M Fishman
Nov 21, 2015·Expert Review of Clinical Immunology·Nina van BeekEnno Schmidt
Jul 6, 2016·Journal of Autoimmunity·Yagang ZuoZhi Liu
Oct 25, 2016·The Journal of Investigative Dermatology·Kentaro IzumiHiroshi Shimizu
Nov 22, 2016·The British Journal of Dermatology·C W X TanH Y Lee
Mar 21, 2017·Archives of Dermatological Research·Yi-Di LiuLi Li
Jul 28, 2017·Journal of Dermatological Science·Teruki DainichiKenji Kabashima
Aug 24, 2017·Experimental Dermatology·Dagmar SimonHans-Uwe Simon
Feb 10, 2018·Archives of Dermatological Research·Maryam DaneshpazhoohCheyda Chams-Davatchi
Mar 14, 2018·The Journal of Investigative Dermatology·Mayumi KamaguchiHiroshi Shimizu
Apr 10, 2018·International Journal of Dermatology·Adriana T LopezLarisa Geskin
Sep 5, 2018·Frontiers in Medicine·Khalaf Kridin, Ralf J Ludwig
Nov 6, 2018·Journal of the European Academy of Dermatology and Venereology : JEADV·M ZhengH Shimizu
Jan 10, 2019·JAMA Dermatology·Khalaf Kridin, Reuven Bergman
May 16, 2019·Anais Brasileiros De Dermatologia·Denise MiyamotoCelina Wakisaka Maruta
Jul 6, 2019·Frontiers in Immunology·Kaisa TasanenWataru Nishie

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.